2) 4400 Biscayne Boulevard
Miami, Florida opko.com
Sector: Health Care
Industry: Biotechnology
Employees: 6,096
Note: I live in the FL Keys and have never heard of this firm with over 6,096 employees?
3) DESCRIPTION
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference,as well as . . .
4) point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
5) Summary as of 18 Feb 21
OPEN5.49
PREVIOUS CLOSE5.57
DAY RANGE5.35 - 5.62
52-WEEK RANGE1.12 - 6.47
ALL-TIME HIGH19.20
AVG. VOLUME (50-DAY)8,002,303
EPS (TTM)-0.18
NEXT EARNINGS DATE2/18/2021 (AMC)
LAST EARNINGS DATE10/29/2020
OPTIONSYes
6) Fundamentals
P/E RATIO-
PEG RATIO0.60
PRICE TO BOOK2.30
PRICE TO CASH FLOW-
PRICE TO FREE CASH FLOW-
TOTAL SALES (TTM)1.165 B
REVENUE PER SHARE (TTM)1.82
SHARES OUTSTANDING670.00 M
SHARE FLOAT (%)404.66 M (60.40%)
% HELD BY INSTITUTIONS29.74
DIVIDENDS PER SHARE0.00
Short Float of 25.55%
Short Ratio of 12.50%
And few analysts following
9) Are you a hoops fan?
"Opko Health: BioReference Laboratories, owned by Opko Health (NASDAQ: OPK), was the provider of COVID-19 tests for the NBA this summer when the league operated in a bubble. The AP reported that BioReference . . . " finance.yahoo.com/news/2-small-c…
10) " . . . is working with the NBA for the 2020-2021 season as well. The Opko unit gets $140 per test and may get additional revenue from this partnership this season. The report said BioReference could have personnel traveling with teams to help with the testing."
11) NFL fan? 31 Dec 21 ORCHARD PARK, N.Y., Dec. 31, 2020 /PRNewswire/ -- Buffalo Bills, 2020 AFC East Division Champions, and BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), . . . .finance.yahoo.com/news/buffalo-b…
12) " . . . today announced they will be performing fan testing for the AFC Divisional Wild Card playoff game at Bills Stadium in Orchard Park."
13) 4 Jan 21 - If approved, somatrogon will serve as a once-weekly treatment option –
"Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the US Food and Drug Administration (FDA) . . . .finance.yahoo.com/news/us-fda-ac…
14) " . . . has accepted for filing the initial Biologics License Application (BLA) for somatrogon, a long-acting human growth hormone that is intended to be administered once-weekly for the treatment of pediatric patients with growth hormone deficiency (GHD). "
15) 13 Jan 21 "Patients will no longer need to travel for laboratory services. Healthcare providers will secure vital diagnostic information about patients reliably, quickly and easily to enable a faster diagnosis."
16) "To use Scarlet's convenient, secure and safe approach to mobile specimen collection services, patients will obtain a link after visiting or connecting virtually with their healthcare provider. After confirming the services needed, a patient will verify their identity . . . "
17) "and schedule a date and time, and choose their preferred location (i.e., at their office or home) for a qualified healthcare professional to collect their test specimen. Patients will then receive real-time updates and relevant information, such as learning how . . . "
18) "to prepare for the visit or track the healthcare professional's arrival. Specimens will be sent to BioReference for testing, and the results will be securely shared online with the patient and their ordering healthcare provider."
19) 26 Jan 21 "BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced COVID-19 testing agreements for players and officials, as well as team and league staff for the 2020-2021 seasons. . ." finance.yahoo.com/news/opko-heal…
20) " . . . for the National Basketball Association (NBA) and National Hockey League (NHL)."
23) 19 Feb 21 "Arguably the main thing to watch with OPKO, though, is how COVID-19 testing volumes hold up as vaccines continue to roll out. It's possible that lower efficacy for the vaccines against new coronavirus variants could prolong . . ." fool.com/investing/2021…
24) "the pandemic and boost demand for COVID-19 tests. However, OPKO could also see its COVID-19 testing revenue fall as the year progresses. Worries about this scenario appear to have outweighed the good news from the company's Q4 update."
25) The daily chart one more time:
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1) $JMP just announced earnings AMC, Thu, 18 Feb 21
Before getting started, note this is very thinly traded, and yet yesterday, before earnings announced post-market, it traded 32 x its normal avg volume. So, today, I think we're going to see some madness in this name.
2) In a normal setting, yesterday's candlestick, called a "hanging man" would suggest the next day would be down. However, as always, an Earnings report can change everything on a dime. So, today, I'll follow to see how this all pans out and see if volume goes 100x. My bet? UP.
3) That said, let's "do it"
600 Montgomery Street, Suite 1100
San Francisco, California jmpg.com
Sector: Financial
Industry: Investment Services
Employees: 209
2) 9975 Summers Ridge Road, Suite 200
San Diego, California quidel.com
Sector: Health Care
Industry: Medical Supplies
Employees: 1,250
3) DESCRIPTION
Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions.
1) $PTON has turned bearish. A few days ago I was agnostic; now, were I trading this, I would have gone short this name two days ago. Extended trendline (thin line) shows busted horizontal and trendline support & trading under 50 day moving average.
2) Now that's just the chart look. The insider sales for $PTON since just last December (and especially in the past 10 days) tell you a story, and it is not bullish. Every time an insider vests options, they turn around and sell their shares. I don't see bullish buys here:
3) Be aware of product delays (chip shortages are real), and Buy Now Pay Later - although that is off-loaded to the firm Affirm (IIRC). Then, insider sales, and competition. $NLS and $LULU are not asleep during this exercise from home quarantine.
2) 3911 Sorrento Valley Boulevard, Suite 110
San Diego, California ligand.com
Sector: Health Care
Industry: Biotechnology
Employees: 115
3) DESCRIPTION
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines.
1) Bulls vs. Bears Thread: A very bullish look: "The fact these extreme breadth readings keep pouring in as the rally progresses suggests we continue to be in a healthy market that is being driven by broadening participation." allstarcharts.com/february-confe…
2) "Most importantly, this is strong evidence that we are most likely at the beginning of a new bull market, not the end of an old one."
3) From the same link: "Speaking of this whole global growth and reflationary thesis we see playing out, here’s another development to add to the above list… New record highs for Emerging Markets $EEM." (Chart from All-Star Charts piece linked above.)